Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 8/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | GRIN2D | O15399 | 4/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 4/20 | 0.41 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.41 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.41 |
| ▸ | GRIN2C | Q14957 | 4/20 | 0.41 |
| ▸ | GRIN3A | Q8TCU5 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | EBP | Q15125 | 1/20 | 0.41 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2229008 | 1.00 | SIGMAR1 (0.46) | SIGMAR1ESR2ESR1GRIN2DGRIN3B | |
| SCHEMBL5693829 | 0.98 | SIGMAR1 (0.45) | SIGMAR1ESR2ESR1GRIN2DGRIN3B | |
| SCHEMBL5606687 | 0.98 | SIGMAR1 (0.45) | SIGMAR1ESR2ESR1GRIN2DGRIN3B | |
| SCHEMBL5588687 | 0.98 | SIGMAR1 (0.45) | SIGMAR1ESR2ESR1GRIN2DGRIN3B | |
| Hydrochloric Acid SCHEMBL3290040 | 0.96 | SIGMAR1 (0.44) | SIGMAR1ESR2ESR1GRIN2DGRIN3B | |
| Hydrochloric Acid SCHEMBL1539025 | 0.96 | SIGMAR1 (0.44) | SIGMAR1ESR2ESR1GRIN2DGRIN3B | |
| Hydrochloric Acid SCHEMBL1539024 | 0.96 | SIGMAR1 (0.46) | SIGMAR1ESR2ESR1GRIN2DGRIN3B | |
| SCHEMBL15082888 | 0.93 | SIGMAR1 (0.41) | SIGMAR1ESR2ESR1GRIN2DGRIN3B | |
| SCHEMBL15082897 | 0.93 | SIGMAR1 (0.45) | SIGMAR1ESR2ESR1GRIN2DGRIN3B | |
| SCHEMBL12266826 | 0.93 | SIGMAR1 (0.41) | SIGMAR1ESR2ESR1GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1521758-B1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2006-05-24 | — | — | EP | claimed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | claimed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | claimed |
| WO-2023151188-A1 | GREEN SYNTHESIS METHOD OF ANTIVIRAL DRUG INTERMEDIATE | 上海皓元医药股份有限公司 | 2023-08-17 | — | — | WO | disclosed |
| EP-2797862-B1 | OLEFIN OLIGOMERIZATION METHODS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2021-04-07 | — | — | EP | disclosed |
| US-10766979-B2 | Bis-imine pyridine complex of lanthanides catalytic system comprising said bis-imine pyridine complex and process for the (co)polymerization of conjugated dienes | VERSALIS S.P.A. (IT) | 2020-09-08 | — | — | US | disclosed |
| US-10441946-B2 | Linear alpha-olefin catalysts and preparation and use thereof | APALENE TECHNOLOGY CO., LTD. (HANGZHOU) (CN) | 2019-10-15 | — | — | US | disclosed |
| US-10184052-B2 | Near infrared radiation-absorbing composition, near infrared radiation cut-off filter and production method therefor, and camera module and production method therefor | FUJIFILM CORPORATION (JP) | 2019-01-22 | — | — | US | disclosed |
| US-20180147571-A1 | NOVEL LINEAR ALPHA-OLEFIN CATALYSTS AND PREPARATION AND USE THEREOF | APALENE TECHNOLOGY CO., LTD. (JIAXING) (CN) | 2018-05-31 | — | — | US | disclosed |
| US-20180147571-A1 | NOVEL LINEAR ALPHA-OLEFIN CATALYSTS AND PREPARATION AND USE THEREOF | APALENE TECHNOLOGY CO., LTD. (JIAXING) (CN) | 2018-05-31 | — | — | US | disclosed |
| US-20180094086-A1 | NEAR INFRARED ABSORBING COMPOSITION, NEAR INFRARED CUT FILTER, METHOD OF MANUFACTURING NEAR INFRARED CUT FILTER, DEVICE, METHOD OF MANUFACTURING COPPER-CONTAINING POLYMER, AND COPPER-CONTAINING POLYMER | FUJIFILM CORPORATION (JP) | 2018-04-05 | — | — | US | disclosed |
| US-20040068154-A1 | Selective isomerization and linear dimerization of olefins using cobalt catalysts | CHEVRON PHILLIPS CHEMICAL COMPANY | 2004-04-08 | — | — | US | disclosed |
| US-20040068072-A1 | Selective isomerization and linear dimerization of olefins using cobalt catalysts | CHEVRON PHILLIPS CHEMICAL COMPANY | 2004-04-08 | — | — | US | disclosed |
| US-6710006-B2 | BIS-ARYLIMINEPYRIDINE IRON/COBALT COMPLEXES AS SELECTIVE CATALYSTS IN ETHYLENE OLIGOMERIZATION | SHELL OIL COMPANY | 2004-03-23 | — | — | US | disclosed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | disclosed |
| US-20030050494-A1 | Manufacture of alpha-olefins | BROOKHART MAURICE S (US) | 2003-03-13 | — | — | US | disclosed |
| US-20030036615-A1 | Manufacture of alpha-olefins | BROOKHART MAURICE S (US) | 2003-02-20 | — | — | US | disclosed |
| EP-0994831-B1 | MANUFACTURE OF ALPHA-OLEFINS | DU PONT (US) | 2003-01-29 | — | — | EP | disclosed |
| US-6489497-B1 | SELECTED 2,6-PYRIDINEDICARBOXALDEHYDE BISIMINES USEFUL AS TRIDENTATE LIGANDS FOR ETHYLENE OLIGOMERIZATION CATALYSTS | E. I. DU PONT DE NEMOURS AND COMPANY | 2002-12-03 | — | — | US | disclosed |
| US-6103946-A | BY CONTACTING ETHYLENE WITH AN IRON COMPLEX OF A SELECTED 2,6-PYRIDINEDICARBOXALDEHYDE BISIMINE OR A SELECTED 2,6-DIACYLPYRIDINE BISIMINE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180147571-A1 | NOVEL LINEAR ALPHA-OLEFIN CATALYSTS AND PREPARATION AND USE THEREOF | UBE2L3, RNF168, AGL | SIGMAR1 250/4885ESR2 60/4885ESR1 30/4885 |
| US-20030050494-A1 | Manufacture of alpha-olefins | ALOX12, ALOX15B, AP1M1 | SIGMAR1 1623/4885ESR2 533/4885ESR1 830/4885 |
| US-20040068154-A1 | Selective isomerization and linear dimerization of olefins using cobalt catalysts | PPOX, OXER1, OCIAD1 | SIGMAR1 1112/4885ESR2 1000/4885ESR1 1193/4885 |
| US-10441946-B2 | Linear alpha-olefin catalysts and preparation and use thereof | UBE2L3, COG8, ACSL3 | SIGMAR1 436/4885ESR2 84/4885ESR1 43/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.